Workflow guide · Daily and weekly publishing
Identify stories worth deeper coverage
Score events by novelty, evidence, impact, and audience fit.
The situation
When this workflow becomes useful
A newsletter or media team must choose which biotech events deserve a full article rather than a brief mention.
Best fit
Independent writers, newsletter teams, financial media creators, podcasters, and editors covering biotechnology and pharmaceutical companies.
The challenge
Why the obvious approach breaks down
Score events by novelty, evidence, impact, and audience fit. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information.
How to think about the task
The reasoning behind the workflow
A newsletter or media team must choose which biotech events deserve a full article rather than a brief mention. For newsletter writers, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again.
Score events by novelty, evidence, impact, and audience fit. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later.
Start with the decision this work must support
“Identify stories worth deeper coverage” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful.
Build a source-linked change record
The core monitoring set for this workflow includes novelty of evidence, clinical or regulatory importance, audience relevance, competitive read-through, availability of primary sources. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot.
Turn monitoring into an owned output
An editorial scoring queue ranking stories by evidence, impact, audience fit, context opportunity, and reporting effort. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The team reserves deep coverage for events where explanation or synthesis can materially help the reader.
Illustrative example
Illustrative workflow: identify stories worth deeper coverage
Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change.
Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event.
Questions to answer before making a decision
- What has changed in novelty of evidence, and why does it matter?
- What has changed in clinical or regulatory importance, and why does it matter?
- What has changed in audience relevance, and why does it matter?
- What has changed in competitive read-through, and why does it matter?
- What has changed in availability of primary sources, and why does it matter?
The workflow
A repeatable way to do the work
- 01
Define the specific decision or research question behind “identify stories worth deeper coverage.”
- 02
Set the monitored scope around novelty of evidence and clinical or regulatory importance.
- 03
Collect source-linked updates for audience relevance and record what changed from the prior state.
- 04
Review competitive read-through together with availability of primary sources before drawing a conclusion.
- 05
Produce the required output, assign follow-up ownership, and set the next review point.
Monitoring checklist
Signals to keep visible
Common mistakes
- Starting the monitoring process without a defined decision question
- Recording the latest state without preserving its source or previous state
- Ending with collected information but no owner, conclusion, or next review
Output and outcome
What good looks like
Deliverable
An editorial scoring queue ranking stories by evidence, impact, audience fit, context opportunity, and reporting effort.
Practical outcome
The team reserves deep coverage for events where explanation or synthesis can materially help the reader.
Where BioPharmSignal fits
Reduce the collection work around the decision.
Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.
Frequently asked questions
Who is this workflow for?
It is designed for biotech newsletter writers and adjacent biotech research users who need a repeatable, source-linked way to complete this task.
What should this workflow produce?
An editorial scoring queue ranking stories by evidence, impact, audience fit, context opportunity, and reporting effort.
What is the practical benefit?
The team reserves deep coverage for events where explanation or synthesis can materially help the reader.
Related workflows